Third Point discloses approximately 5.8% stake in SRTA
Third Point, associated with Loeb, filed a Schedule 13D and is pushing for strategic alternatives, seeking a strategic review.
Story updates
08:17:07 PM UTC
SquawkNews
Daniel S. Loeb, through Third Point LLC, disclosed a 5.8% stake in Strata Critical Medical, Inc. common stock. The Schedule 13D, filed Oct. 15, 2026, follows an earlier passive 13G and marks a shift to an active stance. Loeb argues the stock is undervalued and the business needs change to create mo…